2004
DOI: 10.1016/s1525-2167(04)80004-0
|View full text |Cite
|
Sign up to set email alerts
|

Clinical application of quantitative analysis in real-time MCE

Abstract: The introduction of stable microbubble contrast agents and technological advances have recently made it feasible to perform quantitative measurements of microvascular damage by myocardial contrast echocardiography (MCE). Qontrast is a new software system far such measurements. It includes physiological filters, global rescale, regional rescale, automatic myocardial tracking, manual ECG trigger and parametric imaging. Qontrast was tested on 5 pigs given sulphur hexafluoride bubbles (I ml/min) and fluorescent mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 30 publications
0
21
0
Order By: Relevance
“…These tools have been tested in animal models (Agati et al 2004;Lafitte et al 2002) and are currently undergoing testing in healthy subjects as well as in patients (Bekeredjian et al 2003;Korosoglou et al 2004;Peltier et al 2004). …”
Section: Discussionmentioning
confidence: 99%
“…These tools have been tested in animal models (Agati et al 2004;Lafitte et al 2002) and are currently undergoing testing in healthy subjects as well as in patients (Bekeredjian et al 2003;Korosoglou et al 2004;Peltier et al 2004). …”
Section: Discussionmentioning
confidence: 99%
“…Myocardial opacification at MCE, the echocardiographic parameter of MD, was visually assessed in each myocardial segment and semiquantitatively scored. Single perfusion score was assigned based on both the change in myocardial signal intensity throughout the replenishment curve and the degree of opacification at the peak contrast effect (11). Scores were graded as 1 ϭ normal (homogeneous opacification approximating that of the normal region at peak and normal rate of increase in signal); 2 ϭ reduced (partial or reduced opacification compared with the normal region at peak or reduced rate of increase in signal intensity); and 3 ϭ absent (no opacification throughout replenishment time).…”
Section: Methodsmentioning
confidence: 99%
“…A contrast score index (CSI) was calculated by the sum of MCE score in each segment divided by the total number of segments. Endocardial length of transmural contrast defect (CD) (score ϭ 3) and of WM abnormality was calculated in each apical view, averaged and expressed as percentage of LV endocardial length, as previously described (10,11). Two experienced observers who had no knowledge of the patient identity or conventional echocardiographic data performed the MCE data analysis.…”
Section: Methodsmentioning
confidence: 99%
“…Investigating coronary microvascular function Lanza et al 7 49 59 MI Perfusion defect Standard echo Ballcells et al 50 30 MI Risk area/no-reflow Dobutamine stress echo Galiuto et al 51 24 MI No-reflow Standard echo Bolognese et al 52 124 MI No-reflow Standard echo Agati et al 53 12 MI No-reflow SPECT Janardhanan et al 54 42 MI No-reflow CMR Moir et al 55 90 CAD Stress perfusion defect Coronary angiography Galiuto et al 56 50 MI No-reflow Standard echo Trindade et al 57 20 MI No-reflow CMR Galiuto et al 58 110 MI No-reflow Coronary angiography Abdelmoneim et al 59 2 HM Vascularity Standard echo Hayat et al 60 83 CAD Stress perfusion defect SPECT Senior et al 61 662 CAD Stress perfusion defect SPECT Mansencal et al 62 31 HM Vascularity Histopathology Galiuto et al 63 20 Takotsubo Perfusion defects Standard echo CAD, stable coronary artery disease; CMR, cardiac magnetic resonance; HM, heart masses; MI, myocardial infarction; SPECT, single-photon emission tomography. tomography (MIBI-SPECT), 69 in detecting and quantifying the extent of no-reflow.…”
Section: Clinical Studiesmentioning
confidence: 99%